Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

The participating NIH Institutes and Centers are issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see  as renewed in .

The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD). Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.

Letter of Intent Due Date(s): 15 days prior to the application due date